Lipiodol Injection
NDC Package 67684-1901-2
Package Information
Lipiodol (ethiodized oil) injection is lipiodol is an oil-based radio-opaque contrast agent indicated for:hysterosalpingography in adultslymphography in adult and pediatric patientsselective hepatic intra-arterial use for imaging tumors in adults with known hepatocellular carcinoma (HCC). This formulation utilizes a injection delivery system. Marketed by Guerbet Llc, this product is identified by NDC 67684-1901 and is authorized under FDA application NDA009190.
Identification & Billing
Clinical Specifications
- Intra-arterial - Administration within an artery or arteries.
- Intralymphatic - Administration within the lymph.
- Intrauterine - Administration within the uterus.
Regulatory & Marketing
Hierarchy Structure
- 67684 - Guerbet Llc
- 67684-1901 - Lipiodol
- 67684-1901-2 - 1 VIAL in 1 CARTON / 10 mL in 1 VIAL
- 67684-1901 - Lipiodol
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (67684-1901). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 67684-1901-2 identifies a specific commercial package of 1 vial in 1 carton / 10 ml in 1 vial of Lipiodol, a human prescription drug labeled by Guerbet Llc. This injection is formulated for intra-arterial; intralymphatic; intrauterine use and contains ethiodized oil as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Guerbet Llc on March 21, 2014. The current certification is valid through December 31, 2026.
How is this Guerbet Llc product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 67684190102. Quantities are measured in per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.